1. Accueil
  2. Node

MédiS Laboratories Awarded Best Pharmaceutical Export Company by CEPEX in 2023

Fondés en 1995, les Laboratoires MediS sont aujourd’hui non seulement le leader du marché tunisien des médicaments génériques, mais aussi un acteur clé de l'industrie pharmaceutique internationale.

Committed to excellence, we manufacture and export innovative and high-quality medicines, contributing to Tunisia's reputation as a hub of innovation and quality in the pharmaceutical sector. We adhere to the strictest international standards and prioritize strong, enduring relationships with all our partners.

Médis Establishes Itself in Senegal and Expands into Sub-Saharan Africa

Submitted by admin on

Following Algeria and the Czech Republic, Médis laboratories set up operations in Senegal on April 14, 2017. Indeed, the pharmaceutical group Sanofi and Médis laboratories confirmed, on that day, the acquisition of Sanofi's shares in the company WPS (WinthropPharma Senegal) by the Médis Group.

A human being's health is priceless but has a cost

Submitted by admin on

In the context of cancer treatment, Tunisia annually allocates over 150 million Tunisian dinars(MDT) for the import of anticancer medications. This is a bill that is becoming increasingly heavy over time. The establishment of NEAPOLIS PHARMA has come to address this urgent national need to prevent any risk of future stock shortages, in addition to enabling significant savings in foreign currency for the Central Pharmacy.

Women and Climate Change

Submitted by admin on

Today, more than 4,000 women, gathered in over 300 cooperatives in southwestern Morocco, earn their living by collecting and pressing argan fruits, as well as manufacturingand selling argan oil," says Professor Zoubida Charrouf.

Multiple Sclerosis (MS): What we know and what we don't yet know!

What we know about Multiple Sclerosis (MS) :

Multiple sclerosis is an inflammatory, chronic and often disabling neurological disease that affects only the Central Nervous System (brain and spinal cord).

The disease is thought to be the result of various mechanisms, the most likely of which is immunological, with antibodies and lymphocytes directed against myelin, leading to its permanent destruction.

When should LMWH be prescribed before air travel?

Economy class syndrome

Deep Vein Thrombosis (DVT) is a well-known and severe condition, and the leading cause of death from pulmonary embolism.

The annual incidence of Thrombo Embolic Disease in the Caucasian population is 1 to 2 per 1000.

Cases of DVT have been described during air travel without attracting the attention of the medical profession or airlines, until the death of a 27-year-old woman at Heathrow airport after a flight from Australia.

Subscribe to